Carregant...
ICAM-1 Targeting, Intracellular Trafficking, and Functional Activity of Polymer Nanocarriers Coated with a Fibrinogen-Derived Peptide for Lysosomal Enzyme Replacement
Enzyme replacement is a viable treatment for diseases caused by genetic deficiency of lysosomal enzymes. However, suboptimal access of enzymes to target sites limits this strategy. Polymer nanocarriers (NCs) coated with antibody against intercellular adhesion molecule 1 (ICAM-1), a protein overexpre...
Guardat en:
| Publicat a: | J Drug Target |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5828777/ https://ncbi.nlm.nih.gov/pubmed/28665212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1061186X.2017.1349771 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|